Griseofulvin Pellets

(Product under development)
Griseofulvin PelletsGriseofulvin (also known as Grisovin, a proprietary name of Glaxo Laboratories) is an antifungal drug that is administered orally.

It is used both in animals and in humans, to treat fungal infections of the skin (commonly known as ringworm) and nails. It is derived from the mold Penicillium griseofulvum.

Available Form:
Griseofulvin Pellets
Griseofulvin Granules

Umang Pharmatech equipments used for production of Griseofulvin Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Griseofulvin Pellets
Systematic (IUPAC) name
Griseofulvin Pellets
Griseofulvin Pellets
Chemical data
(2S,6'R)- 7-chloro- 2',4,6-trimethoxy- 6'-methyl- 3H,4'H-spiro [1-benzofuran- 2,1'-cyclohex[2]ene]- 3,4'-dione
CAS number : 126-07-8
ATC code : D01AA08 D01BA01
PubChem : CID 441140
DrugBank : APRD01004
ChemSpider : 389934
KEGG : D00209
ChEBI : CHEBI:27779
Formula : C17H17ClO6
Mol. mass : 352.766 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech